A possible role of recurrent major depression in risk of fracture [6]

Archives of Internal Medicine

Volumn 167, Issue 21, 2007, Pages 2370-

  O'Brien, Sinead M ^a  

^a St Anne's Day Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

BONE DENSITY; DISEASE SEVERITY; FRACTURE; FRAGILITY FRACTURE; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LETTER; MAJOR DEPRESSION; OSTEOLYSIS; PRIORITY JOURNAL; RISK FACTOR; AGED; DEPRESSION; MIDDLE AGED; NOTE; RECURRENT DISEASE;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; FRACTURES, BONE; HUMANS; MIDDLE AGED; RECURRENCE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 36549033203     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.21.2370-a     Document Type: Letter

References (5)

1. Richards JB, Papaioannou A, Adachi JD, et al; Canadian Multicentre Osteoporosis Study Research Group. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167(2):188-194.
2. Michelson D, Stratakis C, Hill L, et al. Bone mineral density in women with depression. N Engl J Med. 1996;335(16):1176-1181.
3. Mazess RB, Barden H, Ettinger M, Schultz F. Bone density of the radius, spine and proximal femur in osteoporosis. J Bone Miner Res. 1988;3(1):13-18.
4. Dinan TG. The physical consequences of depressive illness. BMJ. 1999;318(7187):826.
5. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab. 2001;86(5):2032-2042.